MILLENNIUM MANAGEMENT LLC - SYROS PHARMACEUTICALS INC ownership

SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 102 filers reported holding SYROS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 7.90 and the average weighting 0.1%.

Quarter-by-quarter ownership
MILLENNIUM MANAGEMENT LLC ownership history of SYROS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$928,000
+52.4%
964,096
+88.4%
0.00%
Q1 2022$609,000
+102.3%
511,824
+454.5%
0.00%
Q4 2021$301,000
-78.7%
92,300
-70.8%
0.00%
-100.0%
Q3 2021$1,414,000
-53.5%
316,375
-43.3%
0.00%
-50.0%
Q2 2021$3,040,000
+140.7%
557,713
+230.4%
0.00%
+100.0%
Q1 2021$1,263,000
-69.4%
168,793
-55.6%
0.00%
-66.7%
Q4 2020$4,126,000
+209.1%
380,266
+151.8%
0.00%
+50.0%
Q3 2020$1,335,000
-18.2%
151,026
-1.3%
0.00%0.0%
Q2 2020$1,632,000
-55.1%
153,063
-70.9%
0.00%
-60.0%
Q4 2019$3,632,000
+1772.2%
525,585
+2699.4%
0.01%
Q3 2019$194,000
-69.5%
18,775
-73.1%
0.00%
-100.0%
Q1 2019$637,000
+18.8%
69,715
-27.5%
0.00%0.0%
Q4 2018$536,000
-74.0%
96,185
-44.4%
0.00%
-66.7%
Q3 2018$2,059,000
-46.3%
172,846
-54.0%
0.00%
-40.0%
Q2 2018$3,834,000
+80.3%
375,466
+129.3%
0.01%
+66.7%
Q1 2018$2,126,000
+27.6%
163,770
+44.7%
0.00%0.0%
Q3 2017$1,666,000
+795.7%
113,206
+872.1%
0.00%
Q1 2017$186,00011,6460.00%
Other shareholders
SYROS PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Ally Bridge Group (NY) LLC 3,439,895$18,747,0004.66%
Bain Capital Life Sciences Investors, LLC 5,785,036$31,528,0002.07%
Omega Fund Management, LLC 2,274,831$12,398,0001.40%
Altium Capital Management LP 1,076,942$5,869,0001.36%
Samsara BioCapital, LLC 2,189,199$10,599,0001.31%
Sio Capital Management, LLC 800,000$4,360,0001.08%
Flagship Pioneering Inc. 2,938,494$16,015,0000.20%
EcoR1 Capital, LLC 1,000,000$5,450,0000.20%
Artal Group S.A. 1,700,000$9,265,0000.19%
ACT CAPITAL MANAGEMENT, LLC 52,500$287,0000.15%
View complete list of SYROS PHARMACEUTICALS INC shareholders